Please refer to JobSuchmaschine in your application
Director, Pricing & Reimbursement
Director, Global Pricing & Reimbursement
Reports to: Executive Director, Global Pricing and Reimbursement
Location: Zurich or Brussels
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed and commercializes Soliris ® (eculizumab), the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two life-threatening ultra-rare disorders. Alexion is also establishing a premier global metabolic rare disease franchise, which includes Kanuma ®(sebelipase alfa) for patients with lysosomal acid lipase deficiency (LAL-D), and Strensiq ®(asfotase alfa) for patients with hypophosphatasia (HPP). In addition, Alexion is advancing the most robust rare disease pipeline in the biotech industry, with highly innovative product candidates in multiple therapeutic areas. As the global leader in complement inhibition, the Company is strengthening and broadening its portfolio of complement inhibitors across diverse platforms, including evaluating potential indications for Soliris in additional severe and ultra-rare disorders. Further information about Alexion can be found at: www.alexion.com.
Alexion’s Global Government Affairs (GGA)/Pricing & Reimbursement (P&R) team is seeking a qualified Director candidate to help develop and execute successful P&R policies and strategies for Alexion’s current and future products in Europe, the Middle East, and Africa (EMEA). Specifically, the Director will assist the GGA/P&R team in assessing and communicating to internal and external stakeholders key issues relating to government affairs and P&R that may impact Alexion, both in the US and globally. The position will support Alexion’s affiliates and partners in P&R negotiations, and will be responsible for helping translate relevant developments into meaningful guidance and strategic advice.
As a key member of the P&R team, the Director is required to have a variety of skills including the ability to:
Qualified candidates should have the following skills:
A BA or BS is required; a graduate degree (MS, MPH, MPP, MBA, JD) is strongly preferred. Qualified candidates should have at least 7-10 years of relevant work experience. International, multi-lingual, and cross-cultural P&R work experience within the pharmaceutical/biotech industry; health economics consulting firms, or industry trade associations would be ideal. Candidates also should have an open mind about new ways to approach P&R issues, particularly for a company like Alexion with a focus on ultra-rare diseases.
As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. To learn more about Alexion, please visit www.alexionpharma.com or download our App for iPhones and Blackberries.